Eosinophil Activation Study for Immune System Diseases

Activation and Function of Eosinophils in Conditions With Blood or Tissue Eosinophilia

Recruiting Observational Study
Immune System Diseases Eosinophilia Helminthiasis Hypersensitivity Parasitic Disease
No Placebo Group Every participant receives an active treatment — no one gets a placebo. No Study Drug Researchers observe your health over time — no experimental treatment is given.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
1 – 100
Sex
Any
Study type
Observational
Participants needed
800 (estimated)
Sponsor
National Institute of Allergy and Infectious Diseases (NIAID) · NIH
Who this trial is looking for

This trial is looking for people with high eosinophil levels or related conditions. Participants will undergo tests to understand how eosinophils function in the body and will provide extra blood samples for research.

Are You a Good Fit for This Trial?

You may be able to join if

  • I am aged between 1 and 100 years old.
  • I have a blood eosinophil count greater than 1500/mm3.
  • I have abnormal eosinophils in my skin or body tissues.
  • I have a doctor for my routine medical care.
  • I understand and can sign a consent document.

You may not be able to join if

  • I have a medical condition that prevents me from participating.
  • I am a pregnant female.

Summarized in plain language from this trial's official eligibility criteria. The full criteria are further down this page — only the research team can confirm whether you qualify.

Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
This study will investigate how, why and under what conditions eosinophils (a type of white blood cell) become activated and will examine their function in immune reactions. Eosinophil counts often rise in response to allergies, asthma, and parasitic worm infections. They can also go up in uncommon autoimmune conditions and, rarely, in association with tumors. Elevated levels of these cells is cal…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
* INCLUSION CRITERIA: To be eligible to participate in this study, an individual must meet all of the following criteria: 1. Stated willingness to comply with all study procedures and availability for the duration of the study 2. Male or female, aged 1-100 3. Ability of subject (or Legally Authori…
Contacts

Lori A Penrod, R.N.

(240) 627-3647

lori.penrod@nih.gov

CONTACT

Amy D Klion, M.D.

(240) 381-6073

amy.klion@nih.gov

CONTACT